pteridines has been researched along with Cardiac Hypertrophy in 2 studies
Cardiac Hypertrophy: Enlargement of the HEART due to chamber HYPERTROPHY, an increase in wall thickness without an increase in the number of cells (MYOCYTES, CARDIAC). It is the result of increase in myocyte size, mitochondrial and myofibrillar mass, as well as changes in extracellular matrix.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ellmers, LJ | 1 |
| Scott, NJ | 1 |
| Medicherla, S | 1 |
| Pilbrow, AP | 1 |
| Bridgman, PG | 1 |
| Yandle, TG | 1 |
| Richards, AM | 1 |
| Protter, AA | 1 |
| Cameron, VA | 1 |
| Sakata, Y | 1 |
| Chancey, AL | 1 |
| Divakaran, VG | 1 |
| Sekiguchi, K | 1 |
| Sivasubramanian, N | 1 |
| Mann, DL | 1 |
2 other studies available for pteridines and Cardiac Hypertrophy
| Article | Year |
|---|---|
Transforming growth factor-beta blockade down-regulates the renin-angiotensin system and modifies cardiac remodeling after myocardial infarction.
Topics: Animals; Cardiomegaly; Down-Regulation; Drug Evaluation, Preclinical; Gene Expression Regulation; He | 2008 |
Transforming growth factor-beta receptor antagonism attenuates myocardial fibrosis in mice with cardiac-restricted overexpression of tumor necrosis factor.
Topics: Analysis of Variance; Animals; Cardiomegaly; Disease Models, Animal; Fetus; Fibrillar Collagens; Fib | 2008 |